Evidence map›Paper›PMID 36112604›Full record

ArticlePloS one2022

"I would watch her with awe as she swallowed the first handful": A qualitative study of pediatric multidrug-resistant tuberculosis experiences in Durban, South Africa.

Shriya Misra, Nirupa Misra, Boitumelo Seepamore, Kerry Holloway, Nalini Singh, Jacqui Ngozo, Vusi Dlamini, Zanele Radebe, Norbert O Ndjeka, Jennifer Furin

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Annals of global health · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Observational
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Shriya MisraThe Health Ninja, Durban, South Africa.ORCID 0000-0001-5337-1233
Nirupa MisraKing Dinuzulu Hospital Complex, Centralized Drug Resistant Tuberculosis Hospital, Durban, South Africa.
Boitumelo SeepamoreUniversity of KwaZulu-Natal, Durban, South Africa.
Kerry HollowayKing Dinuzulu Hospital Complex, Centralized Drug Resistant Tuberculosis Hospital, Durban, South Africa.
Nalini SinghKing Dinuzulu Hospital Complex, Centralized Drug Resistant Tuberculosis Hospital, Durban, South Africa.
Jacqui NgozoKwaZulu-Natal Provincial HAST Unit, Durban, South Africa.
Vusi DlaminiKwaZulu-Natal, Provincial Department of Health, Durban, South Africa.
Zanele RadebeKwaZulu-Natal Provincial HAST Unit, Durban, South Africa.
Norbert O NdjekaNational Department of Health, National TB Control and Management Cluster Office, Pretoria, South Africa.
Jennifer FurinSentinel Project on Pediatric Drug Resistant Tuberculosis, Boston, Massachusetts, United States of America.ORCID 0000-0002-0825-7199
R. K. Khan Hospital · ZADepartment of Health · ZAHarvard University · USUniversity of KwaZulu-Natal · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThere are limited data on the experiences of children being treated for drug-resistant tuberculosis (DR-TB), and most work in the area has been done with older children and adolescents. Comprehensive explorations of the caregiver experiences in this area are also lacking.

objectiveTo describe the experiences of being treated for drug-resistant tuberculosis of children and their caregivers.

methodsThis was a qualitative study done using focus group discussions (FGDs) among three different groups of participants: 1) health care providers involved in the care of children being treated for DR-TB (including physicians, nurses, and pharmacists)-herein referred to as providers; 2) household caregivers of children being treated for DR-TB-herein referred to as caregivers; and 3) children who were being treated for DR-TB-herein referred to as children. The population was a convenience sample and included children hospitalized between January 1, 2018, and June 30, 2020, ages 0-14 years old, as well as their caregivers and providers. Focus group transcripts and notes were analysed using a thematic network analysis based in grounded theory The analysis was iterative and the coding system developed focused on "stressful experiences" as well as ways to address them along the diagnostic and treatment journey. This paper follows the COREQ guidelines.

results16 children between the ages 7 and 14 years participated in 5 FGDs, 30 caregivers participated in 7 FGDs, and 12 providers participated in 3 FDGs. Data from the children and the caregivers were the focus of this analysis, although some themes were informed by the discussions with the providers as well. In general, it was reported that for a child diagnosed with DR-TB, there is a lived experience of stress that impacts their physical, mental, and social well-being. These pediatric patients and their families therefore develop strategies for coping with these disruptions to their lives. In general, there were major disruptive experiences that resulted from the process around receiving a diagnosis of DR-TB and second distinct set of stressful experiences that occurred during the treatment of DR-TB once the diagnosis had been made. These stresses occur in the physical, mental, and social realms, and families develop multiple strategies to cope with them, demonstrating resilience in the face of this disease.

conclusionAddressing the stresses experienced by children and their caregivers through child-friendly DR-TB testing, treatment, and counseling is not only essential for ending TB but also for enacting a human-rights based approach to child health in general. Children with DR-TB are a vulnerable population, and they have often been the last to benefit from advances in general pediatric care and in DR-TB care more specifically.

Indexed as

Tuberculosis, Multidrug-ResistantAdolescentCaregiversChildFemaleHealth PersonnelHumansQualitative ResearchSouth Africa

Identifiers

PMID36112604
PMCPMC9481007
OpenAlexW4296028919

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.